Oviductal extracellular matrix hydrogels enhance in vitro culture of rabbit embryos and reduce deficiencies during assisted reproductive technologies

Data de publicació:

Autors de IIS La Fe

Autors aliens a IIS La Fe

  • Lorenzo-Rebenaque, Laura
  • Casto-Rebollo, Cristina
  • Vicente, Jose Salvador
  • Marco-Jimenez, Francisco

Grups d'Investigació

Abstract

In vitro embryo culture often falls short of mimicking the physiological dynamism occurring in the reproductive tract, prompting developmental plasticity in mammalian embryos with consequential genotypic and phenotypic deviations. Recent research highlights the potential of biological derivatives in in vitro culture to mitigate these effects, being the extracellular matrix (ECM) one of the most important components in retaining structural and biological signals derived from the native source tissue. Current bioengineering techniques could provide ECM-based biomaterials mimicking the native environment and offering optimal embryonic development. Rabbit oviducts (n = 24) were decellularized and solubilized to create tissue-specific ECM (OviECM) hydrogels. Following physicochemical characterization, these hydrogels were applied as coatings for the in vitro culture of two-cell embryos over 48 h, along with embryos cultured under In vitro control conditions (n = 218/group), which were subsequently transferred to recipient females. A subset of embryos was recovered on day 6 for transcriptomic analysis (n = 75-80/group), while the remaining embryos were used to assess implantation and birth rates. Rabbit weights were monitored over 20 weeks post-delivery, with blood tests conducted at weeks 8 and 20. Bayesian inference methods were used for statistical analysis. Differences were considered relevant if P >= 0.8 (80%). No differences in embryo development and morphology were detected between the OviECM coating and In vitro control conditions. However, embryos cultured on these coatings exhibited upregulation of pathways involved in antigen presentation and immune system activation, as well as, increased cellular response to external stimulus and intracellular protein transport. The implantation and live birth rates were significantly higher in the coating group than in the In vitro control group (30.8% vs. 26.1% and 21.2% vs. 18.1%, respectively). During the first 20 weeks of life, the animals from the coating group showed higher weights than the In vitro control group P0 > 0.8. The animals of both experimental groups showed normal blood parameters. Implementation of OviECM coatings allows for improving in vitro conditions and decreases postnatal phenotypic deviations after assisted reproductive technology (ART). This study could initiate a new embryo culture techniques era to guarantee that ART is utilized in the most efficient and safest possible practice.

Dades de la publicació

ISSN/ISSNe:
2045-2322, 2045-2322

SCIENTIFIC REPORTS  NATURE PUBLISHING GROUP

Tipus:
Article
Pàgines:
-
PubMed:
39528559
Factor d'Impacte:
1,005 SCImago
Quartil:
Q1 SCImago

Documents

  • No hi ha documents

Mètriques

Filiacions

Filiacions no disponibles

Keywords

  • Decellularization; ECM hydrogel; Oviducts; Embryo culture; Phenotype effect

Campos d'Estudi

Projectes associats

Searching for the pathological window of implantation and its therapeutic targets for its clinical translation for precision medicine in reproduction.

Investigador Principal: PATRICIA DÍAZ GIMENO

PI19/00537 . INSTITUTO DE SALUD CARLOS III . 2020

Regenerative medicine based on bioengineering for human reproduction.

Investigador Principal: IRENE CERVELLÓ ALCARAZ

CP19/00149 . INSTITUTO DE SALUD CARLOS III . 2020

Identificación de factores regenerativos en medicina reproductiva y su aplicación como futura herramienta terapéutica para la reparación del endometrio.

Investigador Principal: IRENE CERVELLÓ ALCARAZ

PI17/01039 . INSTITUTO DE SALUD CARLOS III . 2018

Influencia de los disruptores endocrinos sobre la receptividad endometrial humana y su relación con el fallo de impantación y la endometriosis.

Investigador Principal: FRANCISCO DOMÍNGUEZ HERNÁNDEZ

PI17/00931 . INSTITUTO DE SALUD CARLOS III . 2018

Contrato PFIS 2020. Pablo García Acero

Investigador Principal: PATRICIA DÍAZ GIMENO

FI20/00085 . INSTITUTO DE SALUD CARLOS III . 2021

Contratos Miguel Servet I 2020. Patricia Díaz Gimeno.

Investigador Principal: PATRICIA DÍAZ GIMENO

CP20/00118 . INSTITUTO DE SALUD CARLOS III . 2021

Contratos Miguel Servet I 2020. Hortensia Ferrero Chafer

Investigador Principal: HORTENSIA FERRERO CHAFER

CP20/00120 . INSTITUTO DE SALUD CARLOS III . 2021

IMPACTO DE LA INFECCIÓN POR SARS-COV-2 (COVID-19) EN EL ENDOMETRIO HUMANO: EVALUACIÓN IN VITRO DE LOS EFECTOS DE HIDROXICLOROQUINA (HCQ) UTILIZANDO ORGANOIDES ENDOMETRIALES HUMANOS.

Investigador Principal: IRENE CERVELLÓ ALCARAZ

2020-268-1_CRC FERRING COVID_CERVELLO . FERRING PHARMACEUTICALS A/S . 2020

Organoides endometriales de pacientes con endometriosis como modelo para definir mecanismos moleculares implicados en su infertilidad y detectar fármacos de manera personalizada.

Investigador Principal: HORTENSIA FERRERO CHAFER

PI21/00184 . INSTITUTO DE SALUD CARLOS III . 2022

Human organoids to model the healthy female reproductive tract using native bioengineering supports and their pre-clinical applications in the gynecologycal medicine field (Organoides humanos para modelar el tracto reproductivo femenino sano mediante soportes nativos de bioingeniería y sus aplicaciones preclínicas en el campo de la medicina ginecológica).

Investigador Principal: IRENE CERVELLÓ ALCARAZ

PI21/00305 . INSTITUTO DE SALUD CARLOS III . 2022

Efecto de la Vitamina D y los Disruptores Endocrinos sobre la Longitud Telomérica en Células del Cúmulo y los Resultados Reproductivos.

Investigador Principal: ANTONIO PELLICER MARTÍNEZ

PI21/00310 . INSTITUTO DE SALUD CARLOS III . 2022

Contratos Sara Borrell 2021. SEBASTIÁN LEÓN, PATRICIA

Investigador Principal: PATRICIA DÍAZ GIMENO

CD21/00132 . INSTITUTO DE SALUD CARLOS III . 2022

PLASMA RICO EN PLAQUETAS PROCEDENTE DE CORDÓN UMBILICAL PARA EL TRATAMIENTO DE PATOLOGÍAS ENDOMETRIALES (ENDOMETRIO FINO/ SÍNDROME DE ASHERMAN/ ATROFIA ENDOMETRIAL): UN ESTUDIO PILOTO.

Investigador Principal: MÓNICA ROMEU VILLARROYA

2001-FIVI-002-IC . 2021

Creación de organoides endometriales y ováricos mediante el uso de matrices extracelulares desde órganos escelularizados.

Investigador Principal: IRENE CERVELLÓ ALCARAZ

FPU20/00251 . MINISTERIO DE CIENCIA E INNOVACION; MINISTERIO DE UNIVERSIDADES . 2021

Perfiles transcriptómicos y secretómicos tras cultivo extendido de embriones humanos euploides y aneuploides para el cromosoma 21

Investigador Principal: FRANCISCO DOMÍNGUEZ HERNÁNDEZ

CIACIF/2021/051 . CONSELLERIA DE INNOVACIÓN, UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL . 2022

Estudio transcriptómico y secretómico de embriones euploides y aneuploides desde etapas preimplantacionales hasta etapas postimplantacionales tempranas. . AICO. Francisco Domínguez y Patricia Díaz

Investigador Principal: FRANCISCO DOMÍNGUEZ HERNÁNDEZ

CIAICO/2022/203 . CONSELLERIA DE INNOVACIÓN, UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL . 2023

Engineering the human ovary: decellularized ovarian hydrogels for in vitro follicle culture.

Investigador Principal: IRENE CERVELLÓ ALCARAZ

2207-FIVI-090-IC . 2023

ENDOAGE: A molecular clock for endometrial aging as a prognostic tool for improving assisted reproductive treatments (ARTs).

Investigador Principal: ANA MARÍA MONZÓ MIRALLES

2208-FIVI-110-PD . 2024

ENDOAGE: Un reloj molecular de envejecimiento endometrial como herramienta pronóstica para mejorar los tratamientos de reproducción asistida

Investigador Principal: PATRICIA DÍAZ GIMENO

PI23/00806 . INSTITUTO DE SALUD CARLOS III . 2024

Generación de asembloides autólogos linfocerebrales para estudiar la neurotoxicidad asociada a terapia con células car-t: estudio piloto

Investigador Principal: SARA MARÍA GARCÍA GIL-PEROTÍN

PI23/01037 . INSTITUTO DE SALUD CARLOS III . 2024

Comparativa y análisis del potencial regenerativo del plasma rico en plaquetas (PRP) procedente de distintos grupos de edades. Aplicaciones en medicina reproductiva.

Investigador Principal: IRENE CERVELLÓ ALCARAZ

2309-FIVI-170-IC . 2024

BIOBANCO DEL HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE (BIOBANCO LA FE). PLATAFORMA DE BIOBANCOS Y BIOMODELOS

Investigador Principal: JOSÉ VICENTE CERVERA ZAMORA

PT23/00166 . INSTITUTO DE SALUD CARLOS III . 2024

Identificación de microARNs presentes en la sangre y el fluido endometrial de mujeres con adenomiosis como posibles biomarcadores de diagnóstico no invasivo de la enfermedad.

Investigador Principal: ANA CORACHÁN GARCÍA

CIGE/2023/72 . CONSELLERIA DE INNOVACIÓN, UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL . 2024

Compartir la publicació